▶ 調査レポート

C13安定同位体標識生体分子の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global C13 Stable Isotope Labeled Biomolecules Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。C13安定同位体標識生体分子の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global C13 Stable Isotope Labeled Biomolecules Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-03343資料のイメージです。• レポートコード:D005-03343
• 出版社/出版日:GlobalInfoResearch / 2020年5月22日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、C13安定同位体標識生体分子の世界市場を広く調査・分析し、今後の市場展望をまとめております。C13安定同位体標識生体分子の種類別市場規模(医療用C13安定同位体標識生体分子、その他)、用途別市場規模(科学研究、医療、工業、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Cambridge Isotope Laboratories、Omicron Biochemicals、LGC Standards、Sigma-Aldrich、WITEGA Laboratorien、Thermo Fisher Scientific、Medical Isotopes、IsoLife BV、Toronto Research Chemicals、Icon Isotopes
・地域別グローバル市場分析 2015年-2020年
・C13安定同位体標識生体分子の北米市場(アメリカ、カナダ、メキシコ)
・C13安定同位体標識生体分子のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・C13安定同位体標識生体分子のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・C13安定同位体標識生体分子の南米市場(ブラジル、アルゼンチン)
・C13安定同位体標識生体分子の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:医療用C13安定同位体標識生体分子、その他
・用途別分析:科学研究、医療、工業、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global C13 Stable Isotope Labeled Biomolecules market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The C13 Stable Isotope Labeled Biomolecules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
C13 Stable Isotope Labeled Biomolecules market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, C13 Stable Isotope Labeled Biomolecules market has been segmented into
Medical C13 Stable Isotope Labeled Biomolecules
Others

By Application, C13 Stable Isotope Labeled Biomolecules has been segmented into:
Scientific Research
Medical
Industrial
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global C13 Stable Isotope Labeled Biomolecules market presented in the report. This section sheds light on the sales growth of different regional and country-level C13 Stable Isotope Labeled Biomolecules markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global C13 Stable Isotope Labeled Biomolecules market.

The report offers in-depth assessment of the growth and other aspects of the C13 Stable Isotope Labeled Biomolecules market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and C13 Stable Isotope Labeled Biomolecules Market Share Analysis
C13 Stable Isotope Labeled Biomolecules competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, C13 Stable Isotope Labeled Biomolecules sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the C13 Stable Isotope Labeled Biomolecules sales, revenue and market share for each player covered in this report.

The major players covered in C13 Stable Isotope Labeled Biomolecules are:
Cambridge Isotope Laboratories
Omicron Biochemicals
LGC Standards
Sigma-Aldrich
WITEGA Laboratorien
Thermo Fisher Scientific
Medical Isotopes
IsoLife BV
Toronto Research Chemicals
Icon Isotopes

Among other players domestic and global, C13 Stable Isotope Labeled Biomolecules market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe C13 Stable Isotope Labeled Biomolecules product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of C13 Stable Isotope Labeled Biomolecules, with price, sales, revenue and global market share of C13 Stable Isotope Labeled Biomolecules in 2018 and 2019.
Chapter 3, the C13 Stable Isotope Labeled Biomolecules competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the C13 Stable Isotope Labeled Biomolecules breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, C13 Stable Isotope Labeled Biomolecules market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe C13 Stable Isotope Labeled Biomolecules sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 C13 Stable Isotope Labeled Biomolecules Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global C13 Stable Isotope Labeled Biomolecules Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Medical C13 Stable Isotope Labeled Biomolecules
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global C13 Stable Isotope Labeled Biomolecules Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Industrial
1.3.5 Others
1.4 Overview of Global C13 Stable Isotope Labeled Biomolecules Market
1.4.1 Global C13 Stable Isotope Labeled Biomolecules Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cambridge Isotope Laboratories
2.1.1 Cambridge Isotope Laboratories Details
2.1.2 Cambridge Isotope Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cambridge Isotope Laboratories SWOT Analysis
2.1.4 Cambridge Isotope Laboratories Product and Services
2.1.5 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Omicron Biochemicals
2.2.1 Omicron Biochemicals Details
2.2.2 Omicron Biochemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Omicron Biochemicals SWOT Analysis
2.2.4 Omicron Biochemicals Product and Services
2.2.5 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 LGC Standards
2.3.1 LGC Standards Details
2.3.2 LGC Standards Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 LGC Standards SWOT Analysis
2.3.4 LGC Standards Product and Services
2.3.5 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sigma-Aldrich
2.4.1 Sigma-Aldrich Details
2.4.2 Sigma-Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sigma-Aldrich SWOT Analysis
2.4.4 Sigma-Aldrich Product and Services
2.4.5 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 WITEGA Laboratorien
2.5.1 WITEGA Laboratorien Details
2.5.2 WITEGA Laboratorien Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 WITEGA Laboratorien SWOT Analysis
2.5.4 WITEGA Laboratorien Product and Services
2.5.5 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Medical Isotopes
2.7.1 Medical Isotopes Details
2.7.2 Medical Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Medical Isotopes SWOT Analysis
2.7.4 Medical Isotopes Product and Services
2.7.5 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 IsoLife BV
2.8.1 IsoLife BV Details
2.8.2 IsoLife BV Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 IsoLife BV SWOT Analysis
2.8.4 IsoLife BV Product and Services
2.8.5 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Toronto Research Chemicals
2.9.1 Toronto Research Chemicals Details
2.9.2 Toronto Research Chemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Toronto Research Chemicals SWOT Analysis
2.9.4 Toronto Research Chemicals Product and Services
2.9.5 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Icon Isotopes
2.10.1 Icon Isotopes Details
2.10.2 Icon Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Icon Isotopes SWOT Analysis
2.10.4 Icon Isotopes Product and Services
2.10.5 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Manufacturer (2018-2019)
3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 C13 Stable Isotope Labeled Biomolecules Manufacturer Market Share in 2019
3.3.2 Top 6 C13 Stable Isotope Labeled Biomolecules Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Market Share by Regions
4.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Regions (2015-2020)
4.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Regions (2015-2020)
4.2 North America C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
4.3 Europe C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
4.5 South America C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Market Share by Country
5.1.1 North America C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Country (2015-2020)
5.1.2 North America C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Country (2015-2020)
5.2 United States C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
5.3 Canada C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
5.4 Mexico C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Market Share by Country
6.1.1 Europe C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Country (2015-2020)
6.1.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Country (2015-2020)
6.2 Germany C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
6.3 UK C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
6.4 France C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
6.5 Russia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
6.6 Italy C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Regions (2015-2020)
7.2 China C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
7.3 Japan C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
7.4 Korea C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
7.5 India C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
7.6 Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
7.7 Australia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Market Share by Country
8.1.1 South America C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Country (2015-2020)
8.1.2 South America C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Country (2015-2020)
8.2 Brazil C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
8.3 Argentina C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
9.3 Turkey C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
9.4 Egypt C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
9.5 South Africa C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global C13 Stable Isotope Labeled Biomolecules Sales and Market Share by Type (2015-2020)
10.2 Global C13 Stable Isotope Labeled Biomolecules Revenue and Market Share by Type (2015-2020)
10.3 Global C13 Stable Isotope Labeled Biomolecules Price by Type (2015-2020)
11 Global C13 Stable Isotope Labeled Biomolecules Market Segment by Application
11.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
11.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2015-2020)
11.3 Global C13 Stable Isotope Labeled Biomolecules Price by Application (2015-2020)
12 Market Forecast
12.1 Global C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Growth Rate (2021-2025)
12.2 C13 Stable Isotope Labeled Biomolecules Market Forecast by Regions (2021-2025)
12.2.1 North America C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025)
12.2.2 Europe C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025)
12.2.3 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025)
12.2.4 South America C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025)
12.2.5 Middle East & Africa C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025)
12.3 C13 Stable Isotope Labeled Biomolecules Market Forecast by Type (2021-2025)
12.3.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Type (2021-2025)
12.3.2 Global C13 Stable Isotope Labeled Biomolecules Market Share Forecast by Type (2021-2025)
12.4 C13 Stable Isotope Labeled Biomolecules Market Forecast by Application (2021-2025)
12.4.1 Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Application (2021-2025)
12.4.2 Global C13 Stable Isotope Labeled Biomolecules Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global C13 Stable Isotope Labeled Biomolecules Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of C13 Stable Isotope Labeled Biomolecules by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global C13 Stable Isotope Labeled Biomolecules Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Cambridge Isotope Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Major Business
Table 9. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 10. Cambridge Isotope Laboratories SWOT Analysis
Table 11. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product and Services
Table 12. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Omicron Biochemicals Basic Information, Manufacturing Base and Competitors
Table 14. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Major Business
Table 15. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 16. Omicron Biochemicals SWOT Analysis
Table 17. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product and Services
Table 18. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. LGC Standards Basic Information, Manufacturing Base and Competitors
Table 20. LGC Standards C13 Stable Isotope Labeled Biomolecules Major Business
Table 21. LGC Standards C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 22. LGC Standards SWOT Analysis
Table 23. LGC Standards C13 Stable Isotope Labeled Biomolecules Product and Services
Table 24. LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 26. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Major Business
Table 27. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 28. Sigma-Aldrich SWOT Analysis
Table 29. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product and Services
Table 30. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. WITEGA Laboratorien Basic Information, Manufacturing Base and Competitors
Table 32. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Major Business
Table 33. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 34. WITEGA Laboratorien SWOT Analysis
Table 35. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product and Services
Table 36. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 38. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Major Business
Table 39. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 40. Thermo Fisher Scientific SWOT Analysis
Table 41. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product and Services
Table 42. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Medical Isotopes Basic Information, Manufacturing Base and Competitors
Table 44. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Major Business
Table 45. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 46. Medical Isotopes SWOT Analysis
Table 47. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product and Services
Table 48. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. IsoLife BV Basic Information, Manufacturing Base and Competitors
Table 50. IsoLife BV C13 Stable Isotope Labeled Biomolecules Major Business
Table 51. IsoLife BV C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 52. IsoLife BV SWOT Analysis
Table 53. IsoLife BV C13 Stable Isotope Labeled Biomolecules Product and Services
Table 54. IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Toronto Research Chemicals Basic Information, Manufacturing Base and Competitors
Table 56. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Major Business
Table 57. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 58. Toronto Research Chemicals SWOT Analysis
Table 59. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product and Services
Table 60. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Icon Isotopes Basic Information, Manufacturing Base and Competitors
Table 62. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Major Business
Table 63. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Total Revenue (USD Million) (2017-2018)
Table 64. Icon Isotopes SWOT Analysis
Table 65. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product and Services
Table 66. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturer (2018-2019) (MT)
Table 68. Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global C13 Stable Isotope Labeled Biomolecules Sales by Regions (2015-2020) (MT)
Table 70. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Regions (2015-2020)
Table 71. Global C13 Stable Isotope Labeled Biomolecules Revenue by Regions (2015-2020) (USD Million)
Table 72. North America C13 Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (MT)
Table 73. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 74. North America C13 Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (USD Million)
Table 75. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 76. Europe C13 Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (MT)
Table 77. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 78. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales by Regions (2015-2020) (MT)
Table 80. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Regions (2015-2020) (USD Million)
Table 82. South America C13 Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (MT)
Table 83. South America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 84. South America C13 Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (USD Million)
Table 85. South America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales by Countries (2015-2020) (MT)
Table 87. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Table 90. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2015-2020) (MT)
Table 91. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2015-2020)
Table 92. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2015-2020) (USD Million)
Table 93. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2015-2020)
Table 94. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2015-2020) (MT)
Table 95. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2015-2020)
Table 96. Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Regions (2021-2025) (MT)
Table 97. Global C13 Stable Isotope Labeled Biomolecules Market Share Forecast by Regions (2021-2025)
Table 98. Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Type (2021-2025) (MT)
Table 99. Global C13 Stable Isotope Labeled Biomolecules Market Share Forecast by Type (2021-2025)
Table 100. Global C13 Stable Isotope Labeled Biomolecules Sales Forecast by Application (2021-2025)
Table 101. Global C13 Stable Isotope Labeled Biomolecules Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. C13 Stable Isotope Labeled Biomolecules Picture
Figure 2. Global Sales Market Share of C13 Stable Isotope Labeled Biomolecules by Type in 2019
Figure 3. Medical C13 Stable Isotope Labeled Biomolecules Picture
Figure 4. Others Picture
Figure 5. C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application in 2018
Figure 6. Scientific Research Picture
Figure 7. Medical Picture
Figure 8. Industrial Picture
Figure 9. Others Picture
Figure 10. Global C13 Stable Isotope Labeled Biomolecules Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey C13 Stable Isotope Labeled Biomolecules Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturer in 2019
Figure 31. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 C13 Stable Isotope Labeled Biomolecules Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 C13 Stable Isotope Labeled Biomolecules Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Regions (2015-2020)
Figure 38. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Regions in 2018
Figure 39. North America C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
Figure 40. Europe C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
Figure 42. South America C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020)
Figure 44. North America C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries (2015-2020)
Figure 46. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries in 2018
Figure 47. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries in 2018
Figure 49. United States C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Figure 54. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries in 2019
Figure 55. Germany C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 57. France C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Regions 2019
Figure 62. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Regions 2019
Figure 63. China C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 66. India C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries in 2019
Figure 70. South America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries in 2019
Figure 71. Brazil C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global C13 Stable Isotope Labeled Biomolecules Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025) (MT)
Figure 86. South America Sales C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales C13 Stable Isotope Labeled Biomolecules Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel